HR
Healthcare Realty Trust Inc
Real Estate • CIK: 0001360604
Loading...
Market Cap
$5.93B
P/E (TTM)
-23.9x
Rev Growth (TTM)
-6.9%
Net Margin (TTM)
-20.8%
FCF Yield (TTM)
7.7%
FCF Margin (TTM)
38.7%
Cash Flow Health
Free Cash Flow8/8 positive
TTM$457M
Q4 '25
$132M+16%
Q2 '25
$114M-30%
FCF Margin
TTM38.7%
Q4 '2546.2%+21%
Sector: 13.8%Above Avg
OCF Margin38.7%
OCF/NI-1.86x
CapEx Coverage–
FCF Yield7.7%
FCF Growth (2Y)+19%
Cash Conversion Cycle
0 days
DSO: 0+DIO: 0−DPO: 0
Capital Allocation & Returns
Shareholder Friendly
Total Shareholder YieldTTM
TTM6.7%
Div Yield6.6%
+Buyback (TTM)0.1%
Strong capital returns to shareholders
Dividend & Payout Metrics
Dividend Yield (TTM)6.6%
FCF Payout Ratio85.8%
Free Cash Flow (TTM)$457.1M
Stock Repurchases (TTM)$4.0M
Capital Return / FCF86.6%
Est. Dividends Paid (TTM)$392.0M
Shows how management rewards shareholders
Operational Efficiency & Returns
Return on Invested CapitalTTM
–
P25MedianP75
(med: 0.1%)
DuPont BreakdownROIC = Margin × Turn × (1+D/E)
NOPAT Margin
–
Asset Turnover
0.12x
8Q: 0.11x
Leverage (1+D/E)
1.00x
D/E: 0.00x
Asset & CapEx Efficiency
Asset-based ROIC formula
QUARTERLY TRENDS
Last 8 quarters + TTM
| Metric | TTM | Q4 2025 | Q2 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|---|
Revenue | $1.2B | $286.3M↓3.8% | $297.8M↑0.1% | $297.5M↓0.5% | $299.0M↓3.5% | $309.8M↓1.8% | $315.4M↓0.3% | $316.3M↓3.2% | $326.8M |
Operating Income | $658.9M | $161.8M↓0.5% | $162.5M↓0.9% | $164.1M↓3.7% | $170.5M↑5.8% | $161.1M↓8.0% | $175.1M↓5.2% | $184.6M↓3.3% | $190.9M |
Net Income | $-246.1M | $14.4M↑124.9% | $-57.7M↑63.4% | $-157.9M↓251.8% | $-44.9M↑58.0% | $-106.8M↓14.9% | $-93.0M↑35.3% | $-143.8M↑53.7% | $-310.8M |
Operating Cash Flow | $457.1M | $132.3M↑16.3% | $113.8M↓30.3% | $163.2M↑241.5% | $47.8M↓65.4% | $138.0M↑15.7% | $119.3M↓29.1% | $168.2M↑120.8% | $76.2M |
Free Cash Flow | $457.1M | $132.3M↑16.3% | $113.8M↓30.3% | $163.2M↑241.5% | $47.8M↓65.4% | $138.0M↑15.7% | $119.3M↓29.1% | $168.2M↑120.8% | $76.2M |
Total Equity | N/A |
Valuation Analysis
Fair Value
Price-to-EarningsTTM
-23.9x
Volatile
8Q: -47.6x+23289%
Valuation Lenses
Earnings
-23.9x
vs – sector
Cash Flow
12.9x
EV/FCF vs –
Growth-Adj
–PEG
N/A
Quality-Adj
–P/E per %ROIC
ROIC: –
Shareholder Returns
Dividend
6.6%
Buyback
0.1%
Total Yield
6.7%
Market Cap$5.93B
EV$5.89B
Multi-angle valuation analysis with sector context
Business Quality & Moat
Overall Quality Score
-14/100
Below Average
Composite score: Returns (40%) + Consistency (30%) + Earnings Quality (30%)
Returns on Capital
Return on Equity (ROE)Above Avg
-5.0%
8Q:–
Return on Invested Capital (ROIC)
–
8Q:–
vs Sector:0.1%
Earnings Quality
Cash Conversion
-1.86x
OCF / Net Income
FCF Consistency
–
Positive quarters
Competitive Moat Indicators
Pricing Power
Gross Margin–
Capital Efficiency
Invested Capital Turnover–
Working Capital
Cash Conversion Cycle0 days
Growth Quality & Momentum
Moderate Growth
Growth Quality Score
52/100
Growth 40%
Margins 30%
FCF 20%
Consistency 10%
Growth Rates
Revenue Growth YoY
-6.9%
OpInc Growth YoY
0.4%
EPS Growth YoY
60.3%
FCF 3Y CAGR
18.8%
Growth Quality Analysis
✓Efficient Growth: Free cash flow growing faster than revenue
Margin Quality & Sustainability
Moderate
Profitability Cascade
Gross
—
Operating
—
Net
-20.8%
Margins Unknown
Earnings Quality Signals
SBC / Revenue
—
FCF vs Net Gap
+59.6 pts
FCF: 38.7% | Net: -20.8%
Quality = stability + cash conversion + low dilution
Balance Sheet & Solvency
Fortress
Net Debt / EBITDA
Net Cash
(0.0x)Net Cash: $26.17M
Interest Coverage
–
+Net cash position: $26.17M
Leverage Metrics
Debt-to-Equity
0.00x
Balance sheet risk & solvency analysis